Live from the NIH registry
Studies recruiting near Palm Bay right now
Top 25 of 62 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3
Interventional 59 participants sought
Knight Neurology — Rockledge, Florida (27.1 mi)
· Sponsor: Takeda
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Cancer Care Centers of Brevard — Rockledge, Florida (27.1 mi)
· Sponsor: Agendia
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Cancer Care Centers of Brevard, Inc. — Palm Bay, Florida (6.5 mi)
· Sponsor: Pfizer
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Merritt Island Medical Research, LLC — Merritt Island, Florida (27.4 mi)
· Sponsor: Bristol-Myers Squibb
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
Merritt Island Medical Research, LLC — Merritt Island, Florida (27.4 mi)
· Sponsor: Eli Lilly and Company
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12079 — Melbourne, Florida (8.9 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Kidney Disease
Phase 3
Interventional 347 participants sought
Panoramic Health - Florida Kidney Physicians, LLC (Melbourne) — Melbourne, Florida (8.9 mi)
· Sponsor: Takeda
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
HIV Infections
Phase 3
Interventional 564 participants sought
GSK Investigational Site — Vero Beach, Florida (27.6 mi)
· Sponsor: ViiV Healthcare
The Preeclampsia Registry
Preeclampsia, Eclampsia
N/A
Observational 20,000 participants sought
Preeclampsia Foundation — Melbourne, Florida (8.9 mi)
· Sponsor: Preeclampsia Foundation
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Viera, Florida (20.2 mi)
· Sponsor: Akero Therapeutics, Inc
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
Mild Cognitive Impairment, Alzheimer's Disease
N/A
Observational 1,200 participants sought
Clincloud — Melbourne, Florida (8.9 mi)
· Sponsor: GAP Innovations, PBC
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Viera, Florida (20.2 mi)
· Sponsor: 89bio, Inc.
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 1,000 participants sought
Local Institution - 1131 — Viera, Florida (20.2 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Cancer Care Centers of Breevard — Rockledge, Florida (27.1 mi)
· Sponsor: Revolution Medicines, Inc.
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 490 participants sought
Cancer Care Centers of Brevard- Rockledge /ID# 277853 — Rockledge, Florida (27.1 mi)
· Sponsor: AbbVie
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Cancer Care Centers of Brevard, Inc. — Palm Bay, Florida (6.5 mi)
· Sponsor: Pfizer
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Phase 3
Interventional 850 participants sought
Neurocrine Clinical Site — Palm Bay, Florida (6.5 mi)
· Sponsor: Neurocrine Biosciences
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Melbourne, Florida (8.9 mi)
· Sponsor: Alnylam Pharmaceuticals
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Small-cell Lung Cancer
Phase 3
Interventional 480 participants sought
Zai Lab Site 02020 — Rockledge, Florida (27.1 mi)
· Sponsor: Zai Lab (Shanghai) Co., Ltd.
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 150 participants sought
Merritt Island Medical Research, LLC — Merritt Island, Florida (27.4 mi)
· Sponsor: Eli Lilly and Company
MYLUNG Consortium Part 3: Observational Study
Carcinoma, Non-Small-Cell Lung
N/A
Observational 7,500 participants sought
Cancer Care Centers of Brevard, Inc. — Palm Bay, Florida (6.5 mi)
· Sponsor: US Oncology Research
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Viera, Florida (20.2 mi)
· Sponsor: GlaxoSmithKline
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - 007-926-C — Vero Beach, Florida (27.6 mi)
· Sponsor: Mirati Therapeutics Inc.
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Chronic Total Occlusion of Artery of the Extremities
N/A
Interventional 65 participants sought
Vascular & Embolization Specialists — Cocoa, Florida (29.7 mi)
· Sponsor: Versono Medical Ltd
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Neovascular (Wet) Age-Related Macular Degeneration
Phase 1, Phase 2
Interventional 215 participants sought
Florida Eye Associates — Melbourne, Florida (8.9 mi)
· Sponsor: 4D Molecular Therapeutics